Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients (Q46729998)

24 December 2017

title

Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients (English)

1 reference

24 December 2017

0 references

Roman Pfister

1

1 reference

24 December 2017

Holger Diedrichs

2

1 reference

24 December 2017

Anne Schiedermair

3

1 reference

24 December 2017

Stephan Rosenkranz

4

1 reference

24 December 2017

Martin Hellmich

5

1 reference

24 December 2017

Erland Erdmann

6

1 reference

24 December 2017

Christian Alfons Schneider

7

1 reference

24 December 2017

publication date

4 March 2008

1 reference

24 December 2017

European Journal of Heart Failure

published in

1 reference

24 December 2017

volume

10

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

315-320

1 reference

24 December 2017

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Predictors of late development of heart failure in stable survivors of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

The Seattle Heart Failure Model: prediction of survival in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Natural history of asymptomatic left ventricular systolic dysfunction in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Use of NT-proBNP in routine testing and comparison to BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Assessing kidney function--measured and estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Predictors of mortality and morbidity in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Controlled trial of effect of documented cardiovascular risk scores on prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

NT-pro-BNP measured at discharge predicts outcome in multimorbid diabetic inpatients with a broad spectrum of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

N-terminal pro-brain natriuretic peptide A new gold standard in predicting mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Comparison of B-type natriuretic peptide levels in patients with heart failure with versus without mitral regurgitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Usefulness of N-terminal pro-B-type natriuretic peptide to predict clinical course in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Renal function as a predictor of outcome in a broad spectrum of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2008.01.009

10.1016/J.EJHEART.2008.01.009

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18304872

1 reference

24 December 2017